SCHEMBL16658745

SCHEMBL16658745

CCCCCCCCCCCCC/C=C/C(=O)NC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMB11 A5LHX3 1/20 0.54
PSMA7 O14818 1/20 0.54
PSMB1 P20618 1/20 0.54
PSMA1 P25786 1/20 0.54
PSMA2 P25787 1/20 0.54
PSMA3 P25788 1/20 0.54
PSMA4 P25789 1/20 0.54
PSMB8 P28062 1/20 0.54
PSMB9 P28065 1/20 0.54
PSMA5 P28066 1/20 0.54
PSMB4 P28070 1/20 0.54
PSMB6 P28072 1/20 0.54
PSMB5 P28074 1/20 0.54
PSMB10 P40306 1/20 0.54
PSMB3 P49720 1/20 0.54
PSMB2 P49721 1/20 0.54
PSMA6 P60900 1/20 0.54
PSMA8 Q8TAA3 1/20 0.54
PSMB7 Q99436 1/20 0.54
PPARG P37231 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16658739 1.00 PSMB11 (0.54) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL16658734 1.00 PSMB11 (0.54) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL16658735 1.00 PSMB11 (0.54) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL16658736 1.00 PSMB11 (0.54) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL10016300 1.00 PSMB11 (0.54) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL16658738 1.00 PSMB11 (0.54) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL16658737 1.00 PSMB11 (0.54) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL12048773 0.94 PSMB11 (0.53) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL29498993 0.92 PSMB11 (0.45) PSMB11PSMA7PSMB1PSMA1PSMA2
SCHEMBL9806254 0.92 CHRNB2 (0.47) PSMB11PSMA7PSMB1PSMA1PSMA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2852581-B1 NOVEL 1,3-BENZOXAZOL-2(3H)-ONES AND THEIR USE AS MEDICAMENTS AND COSMETICS WOLFF AUGUST GMBH & CO KG ARZNEIMITTEL DR (DE) 2016-05-04 EP disclosed
US-9199948-B2 1,3-benzoxazol-2(3H)-ones and their use as medicaments and cosmetics DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2015-12-01 US disclosed
US-9199948-B2 1,3-benzoxazol-2(3H)-ones and their use as medicaments and cosmetics DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2015-12-01 US disclosed
US-20150111935-A1 NOVEL 1,3-BENZOXAZOL-2(3H)-ONES AND THEIR USE AS MEDICAMENTS AND COSMETICS DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2015-04-23 US disclosed
US-20150111935-A1 NOVEL 1,3-BENZOXAZOL-2(3H)-ONES AND THEIR USE AS MEDICAMENTS AND COSMETICS DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL (DE) 2015-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150111935-A1 NOVEL 1,3-BENZOXAZOL-2(3H)-ONES AND THEIR USE AS MEDICAMENTS AND COSMETICS TRPV1, TRPA1, P2RX3 PSMB11 2528/4885PSMA7 1966/4885PSMB1 2100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.